Clinical Trials Logo

Clinical Trial Summary

The sequence type 131 (ST131) is a predominant lineage among extraintestinal pathogenic Escherichia coli. It plays a major role in the worldwide dissemination of E. coli that produce extended-spectrum beta-lactamase (ESBL). The aim of this study was to describe the epidemiology of ESBL producing ST131clonal group in our university hospital. All patients with an infection due to ESBL E. coli will be prospectively included for a 2-year period. ST131 isolates will be identified and risk factors associated to ST131 will be determined in comparison to non-ST131 ESBL E. coli.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02853708
Study type Observational
Source Centre Hospitalier Universitaire de Besancon
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date January 2017

See also
  Status Clinical Trial Phase
Completed NCT02541695 - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli N/A
Completed NCT03303937 - Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients N/A
Not yet recruiting NCT03869593 - Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
Active, not recruiting NCT02729116 - Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients Phase 2/Phase 3
Completed NCT01324726 - Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms N/A
Completed NCT01406288 - Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 N/A
Not yet recruiting NCT03800147 - Effects of Nutritional Fat on the Growth of Intestinal E. Coli N/A
Completed NCT00167986 - Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care Phase 4
Terminated NCT00362869 - Enteroaggregative E.Coli (EAEC) Phase 1
Completed NCT00167999 - Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units Phase 4
Completed NCT06252428 - Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals